Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
MediPharm Labs Corp. (T.LAB) had Income from Continuous Operations of -11.50M for the most recently reported fiscal quarter, ending 2020-09-30.
| Income Statement Financials | |
-- |
|
-11.24M |
|
-- |
|
-- |
|
-- |
|
-12.58M |
|
-- |
|
-11.58M |
|
-11.58M |
|
-11.50M |
|
|
Income from Continuous Operations |
-11.50M |
-11.50M |
|
-11.50M |
|
-12.58M |
|
-11.60M |
|
136.02M |
|
136.02M |
|
-0.08 |
|
-0.08 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
112.81M |
|
-- |
|
-- |
|
-- |
|
34.52M |
|
78.29M |
|
78.29M |
|
78.29M |
|
139.59M |
|
| Cash Flow Statement Financials | |
-22.87M |
|
-5.57M |
|
26.80M |
|
29.01M |
|
27.38M |
|
-1.63M |
|
3.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.89 |
|
-- |
|
-- |
|
0.18 |
|
0.30 |
|
-214.03% |
|
-338.53% |
|
-338.53% |
|
-- |
|
-311.74% |
|
-302.45% |
|
-28.43M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.49 |
|
0.17 |
|
542.55 |
|
-14.68% |
|
-14.68% |
|
-10.19% |
|
-11.97% |
|
0.75 |
|
-0.21 |
|
-0.17 |
|